272 related articles for article (PubMed ID: 26089182)
1. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
Le Foll B; Payer D; Di Ciano P; Guranda M; Nakajima S; Tong J; Mansouri E; Wilson AA; Houle S; Meyer JH; Graff-Guerrero A; Boileau I
Neuropsychopharmacology; 2016 Jan; 41(2):529-37. PubMed ID: 26089182
[TBL] [Abstract][Full Text] [Related]
2. Occupancy of dopamine D
Di Ciano P; Mansouri E; Tong J; Wilson AA; Houle S; Boileau I; Duvauchelle T; Robert P; Schwartz JC; Le Foll B
Neuropsychopharmacology; 2019 Jun; 44(7):1284-1290. PubMed ID: 30659274
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic doses of buspirone block D3 receptors in the living primate brain.
Kim SW; Fowler JS; Skolnick P; Muench L; Kang Y; Shea C; Logan J; Kim D; Carter P; King P; Alexoff D; Volkow ND
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1257-67. PubMed ID: 24679922
[TBL] [Abstract][Full Text] [Related]
4. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
[TBL] [Abstract][Full Text] [Related]
5. Association of dopamine D
Komorowski A; Weidenauer A; Murgaš M; Sauerzopf U; Wadsak W; Mitterhauser M; Bauer M; Hacker M; Praschak-Rieder N; Kasper S; Lanzenberger R; Willeit M
Neuroimage; 2020 Dec; 223():117270. PubMed ID: 32818617
[TBL] [Abstract][Full Text] [Related]
6. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.
Girgis RR; Slifstein M; D'Souza D; Lee Y; Periclou A; Ghahramani P; Laszlovszky I; Durgam S; Adham N; Nabulsi N; Huang Y; Carson RE; Kiss B; Kapás M; Abi-Dargham A; Rakhit A
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3503-12. PubMed ID: 27525990
[TBL] [Abstract][Full Text] [Related]
7. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
8. The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.
Di Ciano P; Cormick PM; Stefan C; Wong E; Kim A; Remington G; Le Foll B
Psychopharmacology (Berl); 2017 Nov; 234(22):3309-3320. PubMed ID: 28825117
[TBL] [Abstract][Full Text] [Related]
9. Separating dopamine D
Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y
Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639
[TBL] [Abstract][Full Text] [Related]
11. Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [
Chukwueke CC; Nona CN; McPhee MD; Mansouri E; Rubin-Kahana DS; Martinez D; Boileau I; Hendershot CS; Le Foll B
Neuropsychopharmacology; 2021 Nov; 46(12):2112-2120. PubMed ID: 34349232
[TBL] [Abstract][Full Text] [Related]
12. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of cerebral dopamine D3 receptors in alcoholism.
Erritzoe D; Tziortzi A; Bargiela D; Colasanti A; Searle GE; Gunn RN; Beaver JD; Waldman A; Nutt DJ; Bani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A
Neuropsychopharmacology; 2014 Jun; 39(7):1703-12. PubMed ID: 24469594
[TBL] [Abstract][Full Text] [Related]
14. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
[TBL] [Abstract][Full Text] [Related]
15. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
[TBL] [Abstract][Full Text] [Related]
16. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
[TBL] [Abstract][Full Text] [Related]
17. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
[TBL] [Abstract][Full Text] [Related]
18. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
[TBL] [Abstract][Full Text] [Related]
19. Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo.
Gallezot JD; Beaver JD; Gunn RN; Nabulsi N; Weinzimmer D; Singhal T; Slifstein M; Fowles K; Ding YS; Huang Y; Laruelle M; Carson RE; Rabiner EA
Synapse; 2012 Jun; 66(6):489-500. PubMed ID: 22213512
[TBL] [Abstract][Full Text] [Related]
20. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA
Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
